| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-0077 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 |
| filingDate |
2005-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b0c542de908b1e1f9d7075b8d5aecd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f900dd7069faadc446683c105d5f52 |
| publicationDate |
2006-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006228389-A1 |
| titleOfInvention |
Vascular implant device |
| abstract |
Vascular smooth muscle cells (VSMCs) adhere to and orient along micropatterned grooves having a depth of 1 to 10 μm and a width of 1 to 20 μm that are imposed on the surface of a vascular implant device. The VSMCs maintain an elongated morphology and reduced proliferation resulting in a decrease in occurrence of intimal hyperplasia upon device implantation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9976123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808557-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2763710-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7682388-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648135-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603412-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012123519-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008183270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011166251-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11345894-B2 |
| priorityDate |
2005-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |